BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22508420)

  • 1. Development of diffuse alopecia with psoriasis-like eruptions during administration of infliximab for Crohn's disease.
    Kawashima K; Ishihara S; Yamamoto A; Ohno Y; Fukuda K; Onishi K; Kinoshita Y
    Inflamm Bowel Dis; 2013 Mar; 19(3):E33-4. PubMed ID: 22508420
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of diffuse psoriasis with alopecia during treatment of Crohn's disease with infliximab.
    Medkour F; Babai S; Chanteloup E; Buffard V; Delchier JC; Le-Louet H
    Gastroenterol Clin Biol; 2010 Feb; 34(2):140-1. PubMed ID: 20138448
    [No Abstract]   [Full Text] [Related]  

  • 3. Infliximab-induced psoriasis during therapy for Crohn's disease.
    Steinwurz F; Denadai R; Saad-Hossne R; Queiroz ML; Teixeira FV; Romiti R
    J Crohns Colitis; 2012 Jun; 6(5):610-6. PubMed ID: 22398095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of psoriasis scalp with alopecia during treatment of Crohn's disease with infliximab and rapid response to both diseases to ustekinumab.
    Andrisani G; Marzo M; Celleno L; Guidi L; Papa A; Gasbarrini A; Armuzzi A
    Eur Rev Med Pharmacol Sci; 2013 Oct; 17(20):2831-6. PubMed ID: 24174369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab-associated psoriasis in children with Crohn's disease may require withdrawal of anti-tumor necrosis factor therapy.
    Broge T; Nguyen N; Sacks A; Davis M
    Inflamm Bowel Dis; 2013 Apr; 19(5):E75-7. PubMed ID: 23435403
    [No Abstract]   [Full Text] [Related]  

  • 6. Alopecia secondary to anti-tumor necrosis factor-alpha therapy.
    Ribeiro LB; Rego JC; Estrada BD; Bastos PR; Piñeiro Maceira JM; Sodré CT
    An Bras Dermatol; 2015; 90(2):232-5. PubMed ID: 25830994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Infliximab-induced pustular psoriasis in a patient with Crohn's disease].
    Monteagudo Sánchez B; Cabanillas M; Ortiz-Marin S; Gallego-Ojea JC
    Gastroenterol Hepatol; 2009 Mar; 32(3):175-6. PubMed ID: 19233516
    [No Abstract]   [Full Text] [Related]  

  • 8. [A case of psoriasis induced by infliximab treatment for Crohn's disease].
    Jwa YJ; Kim NH; Park HJ; Park JS; Bae WK; Kim KA; Lee JS; Moon YS
    Korean J Gastroenterol; 2010 Nov; 56(5):324-8. PubMed ID: 21099241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab-induced psoriasis in treatment of Crohn's disease-associated ankylosing spondylitis: case report and review of 142 cases.
    Famenini S; Wu JJ
    J Drugs Dermatol; 2013 Aug; 12(8):939-43. PubMed ID: 23986169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary biliary cirrhosis developing in a patient with Crohn's disease during the course of infliximab treatment: the first case in the literature.
    Sisman G; Erzin Y; Bal K
    J Crohns Colitis; 2013 Oct; 7(9):e397-8. PubMed ID: 23583098
    [No Abstract]   [Full Text] [Related]  

  • 11. Guttate psoriasis induced by infliximab in a child with Crohn's disease.
    Costa-Romero M; Coto-Segura P; Suarez-Saavedra S; Ramos-Polo E; Santos-Juanes J
    Inflamm Bowel Dis; 2008 Oct; 14(10):1462-3. PubMed ID: 18383177
    [No Abstract]   [Full Text] [Related]  

  • 12. Persistent neutrophilic scarring alopecia triggered by anti-TNF blockade for Crohn's disease.
    Amschler K; Mc Broekaert S; Mohr J; Schön MP; Mößner R
    Eur J Dermatol; 2018 Jun; 28(3):403-405. PubMed ID: 29976546
    [No Abstract]   [Full Text] [Related]  

  • 13. Generalized pustular psoriasis triggered by infliximab in two patients with Crohn's disease.
    Kato Y; Yamamoto T
    J Dermatol; 2013 Nov; 40(11):932-3. PubMed ID: 24127642
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-tumor necrosis factor-α induced systemic lupus erythematosus in a patient with metastatic Crohn's disease--what is the role of anti-TNF antibody?
    Farkas K; Nagy F; Kovács L; Wittmann T; Molnár T
    J Crohns Colitis; 2013 May; 7(4):e143-5. PubMed ID: 22818164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar But Not Identical: Plaque Psoriasis Exacerbation in a Patient With Crohn's Disease After Switching From CT-P13 to SB2 Infliximab Biosimilar.
    Pagnini C; Di Paolo MC; De Angelis G; Torcolacci F; Milano M; Trinca D; Porciello R; Graziani MG
    Inflamm Bowel Dis; 2020 Jul; 26(8):e83-e84. PubMed ID: 32458993
    [No Abstract]   [Full Text] [Related]  

  • 16. Crohn's disease and hidradenitis suppurativa. An uncommon association that responds to infliximab.
    Blazquez I; Gonzalez-Lama Y; Roustan G
    J Crohns Colitis; 2013 Dec; 7(12):e717-8. PubMed ID: 24080248
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of complex perianal fistulas with seton and infliximab in adolescents with Crohn's disease.
    Hukkinen M; Pakarinen MP; Piekkala M; Koivusalo A; Rintala R; Kolho KL
    J Crohns Colitis; 2014 Aug; 8(8):756-62. PubMed ID: 24447625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penile Crohn's disease resolved by infliximab.
    Lee Y; Lee YM; Kim MJ; Choe YH
    J Crohns Colitis; 2013 May; 7(4):e146-9. PubMed ID: 22841132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [How I treat....psoriasis comorbidities by adalimumab (Humira) anti-TNFalpha].
    Piérard-Franchimont C; Henry F; Szepetiuk G; Piérard GE
    Rev Med Liege; 2010 Oct; 65(10):545-8. PubMed ID: 21128358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rare case of free bowel perforation associated with infliximab treatment for stricturing Crohn's disease.
    Lim CS; Moon W; Park SJ; Park MI; Kim HH; Kim JB; Choi JM; Chang HK; Lee SH
    Korean J Gastroenterol; 2013 Sep; 62(3):169-73. PubMed ID: 24077628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.